Shopping Cart 0
Cart Subtotal
USD 0

Piramal Enterprises Ltd (PEL) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 125

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 250

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 375

Details

Piramal Enterprises Ltd (PEL)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Piramal Enterprises Ltd (PEL), formerly Piramal Healthcare Ltd, is a provider of medicines and healthcare finance services. The company offers products such as Critical Care, Consumer Care, BST-CarGel, Phyto Medicines, Anaesthesias, Orthopedic medicines, Halothane, Isoflurane , Sevoflurane and other OTC related medicines. It also offers contract manufacturing and development services, pharma solutions, critical care solutions, imaging services, and other services such as fund management, structured investments and information management services. The company serves life sciences, financial services,health care, health care information management, specialty glass packaging and real estate sectors. It operates over 110 countries, including, India, Sri Lanka, Germany, Italy, the UK, France, Canada, the US and other countries. PEL is headquartered in Mumbai, Maharashtra, India.

Piramal Enterprises Ltd Key Recent Developments

May 07,2019: Piramal Enterprises Limited signs MoU with Canada Pension Plan Investment Board

Feb 21,2019: Supreme Court exempts Saridon from the list of banned FDCs

Nov 20,2018: Piramal Pharma solutions unveils its new cGMP kilo lab suite for active pharmaceutical ingredient (API) at Ennore, Chennai

Oct 05,2018: Piramal Pharma Solutions launches Xcelerate Integrated Solutions

Oct 05,2018: Piramal Pharma Solutions Announces the Launch of Xcelerate Integrated Solutions

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Piramal Enterprises Ltd-Key Facts

Piramal Enterprises Ltd-Key Employees

Piramal Enterprises Ltd-Key Employee Biographies

Piramal Enterprises Ltd-Major Products and Services

Piramal Enterprises Ltd-History

Piramal Enterprises Ltd-Company Statement

Piramal Enterprises Ltd-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Company Overview

Piramal Enterprises Ltd-Business Description

Business Segment: Financial services

Overview

Performance

Key Stats

Business Segment: Healthcare Insight & Analytics

Overview

Performance

Business Segment: Pharma

Overview

Performance

Key Stats

R&D Overview

Piramal Enterprises Ltd-Corporate Strategy

Piramal Enterprises Ltd-SWOT Analysis

SWOT Analysis-Overview

Piramal Enterprises Ltd-Strengths

Piramal Enterprises Ltd-Weaknesses

Piramal Enterprises Ltd-Opportunities

Piramal Enterprises Ltd-Threats

Piramal Enterprises Ltd-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences, Power Financial Deals and Alliances

Piramal Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Piramal Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Piramal Enterprises Ltd, Recent Deals Summary

Section 5-Company's Recent Developments

May 07, 2019: Piramal Enterprises Limited signs MoU with Canada Pension Plan Investment Board

Feb 21, 2019: Supreme Court exempts Saridon from the list of banned FDCs

Nov 20, 2018: Piramal Pharma solutions unveils its new cGMP kilo lab suite for active pharmaceutical ingredient (API) at Ennore, Chennai

Oct 05, 2018: Piramal Pharma Solutions launches Xcelerate Integrated Solutions

Oct 05, 2018: Piramal Pharma Solutions Announces the Launch of Xcelerate Integrated Solutions

Jul 30, 2018: Piramal Enterprises reports consolidated results for the first quarter ended June 30, 2018

Jul 04, 2018: Ujjivan financial services limited partners with Piramal Swasthya to launch mobile primary healthcare programme in Karnataka

May 28, 2018: Piramal Enterprises Limited announces Consolidated Results for the Full Year & Fourth Quarter ended 31 Mar 2018

Apr 02, 2018: Piramal Enterprises Appoints Anand Piramal as Non-Executive Director on its Board

Mar 27, 2018: Piramal Pharma Solutions Wins in Six Categories at the 'CMO Leadership Awards 2018'

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Piramal Enterprises Ltd, Performance Chart (2015-2019)

Piramal Enterprises Ltd, Ratio Charts

Piramal Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Piramal Enterprises Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Piramal Enterprises Ltd, Key Facts

Piramal Enterprises Ltd, Key Employees

Piramal Enterprises Ltd, Key Employee Biographies

Piramal Enterprises Ltd, Major Products and Services

Piramal Enterprises Ltd, History

Piramal Enterprises Ltd, Subsidiaries

Piramal Enterprises Ltd, Key Competitors

Piramal Enterprises Ltd, Ratios based on current share price

Piramal Enterprises Ltd, Annual Ratios

Piramal Enterprises Ltd, Annual Ratios (Cont...1)

Piramal Enterprises Ltd, Annual Ratios (Cont...2)

Piramal Enterprises Ltd, Interim Ratios

Piramal Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Piramal Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Piramal Enterprises Ltd, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Piramal Enterprises Ltd, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Sun Pharmaceutical Industries Ltd

Lupin Ltd

GlaxoSmithKline Pharmaceuticals Ltd

Dr. Reddy's Laboratories Ltd

Cipla Ltd

Biocon Ltd

Aditya Birla Sun Life Insurance Company Limited

Adani Capital Private Limited

Company Profile

Company Profile Title

Piramal Enterprises Ltd (PEL)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Piramal Enterprises Ltd (PEL), formerly Piramal Healthcare Ltd, is a provider of medicines and healthcare finance services. The company offers products such as Critical Care, Consumer Care, BST-CarGel, Phyto Medicines, Anaesthesias, Orthopedic medicines, Halothane, Isoflurane , Sevoflurane and other OTC related medicines. It also offers contract manufacturing and development services, pharma solutions, critical care solutions, imaging services, and other services such as fund management, structured investments and information management services. The company serves life sciences, financial services,health care, health care information management, specialty glass packaging and real estate sectors. It operates over 110 countries, including, India, Sri Lanka, Germany, Italy, the UK, France, Canada, the US and other countries. PEL is headquartered in Mumbai, Maharashtra, India.

Piramal Enterprises Ltd Key Recent Developments

May 07,2019: Piramal Enterprises Limited signs MoU with Canada Pension Plan Investment Board

Feb 21,2019: Supreme Court exempts Saridon from the list of banned FDCs

Nov 20,2018: Piramal Pharma solutions unveils its new cGMP kilo lab suite for active pharmaceutical ingredient (API) at Ennore, Chennai

Oct 05,2018: Piramal Pharma Solutions launches Xcelerate Integrated Solutions

Oct 05,2018: Piramal Pharma Solutions Announces the Launch of Xcelerate Integrated Solutions

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Piramal Enterprises Ltd-Key Facts

Piramal Enterprises Ltd-Key Employees

Piramal Enterprises Ltd-Key Employee Biographies

Piramal Enterprises Ltd-Major Products and Services

Piramal Enterprises Ltd-History

Piramal Enterprises Ltd-Company Statement

Piramal Enterprises Ltd-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Company Overview

Piramal Enterprises Ltd-Business Description

Business Segment: Financial services

Overview

Performance

Key Stats

Business Segment: Healthcare Insight & Analytics

Overview

Performance

Business Segment: Pharma

Overview

Performance

Key Stats

R&D Overview

Piramal Enterprises Ltd-Corporate Strategy

Piramal Enterprises Ltd-SWOT Analysis

SWOT Analysis-Overview

Piramal Enterprises Ltd-Strengths

Piramal Enterprises Ltd-Weaknesses

Piramal Enterprises Ltd-Opportunities

Piramal Enterprises Ltd-Threats

Piramal Enterprises Ltd-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences, Power Financial Deals and Alliances

Piramal Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Piramal Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Piramal Enterprises Ltd, Recent Deals Summary

Section 5-Company's Recent Developments

May 07, 2019: Piramal Enterprises Limited signs MoU with Canada Pension Plan Investment Board

Feb 21, 2019: Supreme Court exempts Saridon from the list of banned FDCs

Nov 20, 2018: Piramal Pharma solutions unveils its new cGMP kilo lab suite for active pharmaceutical ingredient (API) at Ennore, Chennai

Oct 05, 2018: Piramal Pharma Solutions launches Xcelerate Integrated Solutions

Oct 05, 2018: Piramal Pharma Solutions Announces the Launch of Xcelerate Integrated Solutions

Jul 30, 2018: Piramal Enterprises reports consolidated results for the first quarter ended June 30, 2018

Jul 04, 2018: Ujjivan financial services limited partners with Piramal Swasthya to launch mobile primary healthcare programme in Karnataka

May 28, 2018: Piramal Enterprises Limited announces Consolidated Results for the Full Year & Fourth Quarter ended 31 Mar 2018

Apr 02, 2018: Piramal Enterprises Appoints Anand Piramal as Non-Executive Director on its Board

Mar 27, 2018: Piramal Pharma Solutions Wins in Six Categories at the 'CMO Leadership Awards 2018'

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Piramal Enterprises Ltd, Performance Chart (2015-2019)

Piramal Enterprises Ltd, Ratio Charts

Piramal Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Piramal Enterprises Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Piramal Enterprises Ltd, Key Facts

Piramal Enterprises Ltd, Key Employees

Piramal Enterprises Ltd, Key Employee Biographies

Piramal Enterprises Ltd, Major Products and Services

Piramal Enterprises Ltd, History

Piramal Enterprises Ltd, Subsidiaries

Piramal Enterprises Ltd, Key Competitors

Piramal Enterprises Ltd, Ratios based on current share price

Piramal Enterprises Ltd, Annual Ratios

Piramal Enterprises Ltd, Annual Ratios (Cont...1)

Piramal Enterprises Ltd, Annual Ratios (Cont...2)

Piramal Enterprises Ltd, Interim Ratios

Piramal Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Piramal Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Piramal Enterprises Ltd, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Piramal Enterprises Ltd, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Sun Pharmaceutical Industries Ltd

Lupin Ltd

GlaxoSmithKline Pharmaceuticals Ltd

Dr. Reddy's Laboratories Ltd

Cipla Ltd

Biocon Ltd

Aditya Birla Sun Life Insurance Company Limited

Adani Capital Private Limited